Question to the Department for International Development:

To ask the Secretary of State for International Development, whether it is her Department's policy to implement the recommendation in the report by the UN High Panel of Access to Medicines, Promoting innovation and access to health technologies, published in September 2016, on improving standards of transparency in the pharmaceutical industry.

While we support the aims of the UN High Level Panel on Access to Medicines, we note that this panel of experts could not reach consensus. DFID supports improving transparency in the pharmaceutical industry and funds the Access to Medicine Index to increase the transparency of pharmaceutical companies.